NuvaRing Lawsuit News: NuvaRing Multicounty Litigation (MCL) Convened June 19 Amid News of First NuvaRing Lawsuit Going to Trial

nuvaringThe NuvaRing mass tort in New Jersey recently convened on June 19, 2013 for a case management conference amid news that the first NuvaRing lawsuit consolidated into the mass tort would be going to trial around the same time.

Carey Danis & Lowe NuvaRing lawyers see significant progress being made in the NuvaRing multicounty litigation (MCL). As a NuvaRing law firm representing women who claim injury from from the NuvaRing contraceptive device, Carey Danis & Lowe strong believes these plaintiffs deserve their day in court.

As of May 31, 2013, there are more than 200 cases that have been consolidated into the NuvaRing MCL in the Superior Court of New Jersey in Bergen County. The case is In re: NuvaRing Litigation BER-L-3081-09, and is being presided over by Judge Brian R. Martinotti.

For women seeking to learn more about NuvaRing side effects, Carey Danis & Lowe has created a NuvaRing information page intended to educate the public about the history of the contraceptive device along with data about health complications linked to the device.

Plaintiffs who have filed NuvaRing lawsuits have claimed that the contraceptive device causes blood clots, heart attack, stroke, deep vein thrombosis (DVT), and in some cases, death. According to the New Jersey Superior Court website, one of the cases consolidated into the NuvaRing MCL charges the NuvaRing device with creating deep vein thrombosis, leading to the death of a woman in her thirties.

Carey Danis & Lowe NuvaRing lawyers are currently offering free legal evaluations to women who suffered injuries resulting from use of the NuvaRing contraceptive device. Our NuvaRing lawyers are available to discuss legal options, and can assist in filing NuvaRing lawsuits.

To contact a Carey Danis & Lowe NuvaRing lawyer, call our law offices at 800.721.2519 or submit a personal injury claim form.

References: NuvaRing, Pharmaceutical litigation
Tags: , , , , , ,